TDC
GMED icon

Thompson Davis & Co’s Globus Medical GMED Stock Holding History

Thompson Davis & Co’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$378K Buy
+6,660
New +$350K 0.82% 28
2018
Q2 		– Sell
-2,400
Closed -$120K – 694
2018
Q1 		$120K Buy
2,400
+2,275
+1,820% +$107K 0.32% 76
2017
Q4 		$5K Sell
125
-378
-75% -$13.2K 0.01% 518
2017
Q3 		$15K Buy
503
+253
+101% +$7.72K 0.03% 563
2017
Q2 		$8K Buy
250
+125
+100% +$3.93K 0.01% 720
2017
Q1 		$4K Buy
+125
New +$3.41K 0.01% 931

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Thompson Davis & Co's GMED Position: Q3 2018 in Review

Thompson Davis & Co opened a new position in Globus Medical (GMED) in Q3 2018: 6,660 shares worth $378K. The stake represents 0.82% of the portfolio and ranks #28 among its holdings. This is a return to the name: Thompson Davis & Co previously reported a position in GMED as recently as Q1 2018.

Thompson Davis & Co first reported a position in GMED in Q1 2017 and has held it in 6 quarters since. 312 funds tracked by Wall St. Rank hold GMED as of Q3 2018.

  • Thompson Davis & Co held 6,660 shares of Globus Medical worth $378K as of Q3 2018.
  • Globus Medical was a new Thompson Davis & Co position in Q3 2018.
  • Globus Medical made up 0.82% of Thompson Davis & Co's portfolio in Q3 2018, its #28 holding.
  • Thompson Davis & Co first reported a position in Globus Medical in Q1 2017 and has held it in 6 quarters since.
  • 312 funds tracked by Wall St. Rank held Globus Medical as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.